Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

Authors:

Abstract
Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited testing policies to confirm SARS-CoV-2 infection. Recently, it was shown that it is possible to predict COVID-19 cases using cross-sectional self-reported disease-related symptoms. Here, we demonstrate that this COVID-19 prediction model has reasonable and consistent performance across multiple independent cohorts and that our attempt to improve upon this model did not result in improved predictions. Using the existing COVID-19 prediction model, we then conducted a GWAS on the predicted phenotype using a total of 1,865 predicted cases and 29,174 controls. While we did not find any common, large-effect variants that reached genome-wide significance, we do observe suggestive genetic associations at two SNPs (rs11844522, p = 1.9x10-7; rs5798227, p = 2.2x10-7). Explorative analyses furthermore suggest that genetic variants associated with other viral infectious diseases do not overlap with COVID-19 susceptibility and that severity of COVID-19 may have a different genetic architecture compared to COVID-19 susceptibility. This study represents a first effort that uses a symptom-based predicted phenotype as a proxy for COVID-19 in our pursuit of understanding the genetic susceptibility of the disease. We conclude that the inclusion of symptom-based predicted cases could be a useful strategy in a scenario of limited testing, either during the current COVID-19 pandemic or any future viral outbreak.
All Related Versions
Funding Information
  • Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6)
  • Scottish Funding Council (HR03006)
  • Wellcome Trust (216767/Z/19/Z)
  • Wellcome Trust (Strategic Award “STratifying Resilience and Depression Longitudinally” (STRADL) Reference 104036/Z/14/Z)
  • MRC University Unit Programme Grant (MC_UU_00007/10)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (SPI 92-266)
  • NWO Corona Fast-Track grant (440.20.001)
  • Oncode Senior Investigator grant
  • European Research Council (637640 ImmRisk)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO VIDI grant 917.14.374)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (440.20.022)
  • Netherlands Organisation for Health Research and Development (480-15-001/674)
  • Medical Research Council UK
  • NHS Research Scotland
  • Universities of Scotland
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • helix opco, llc
  • Dutch Ministry of Health, Welfare and Sport
  • Dutch Ministry of Economic Affairs
  • University Medical Center Groningen
  • University of Groningen
  • northern provinces of the netherlands
  • umcg genetics lifelines initiative